Article

Description of Resource:

The U.S. Preventive Services Task Force recommends that clinicians discuss chemoprevention with women at high risk for breast cancer and at low risk for adverse effects of chemoprevention. Clinicians should inform patients of the potential benefits and harms of chemoprevention.

Evidence-Based Resource Details

Learn more about EBR criteria

Developed By:

U.S. Preventive Services Task Force

Developer Type:

Federal Government

Healthy People 2020 Topic Area(s):

Cancer

Healthy People 2020 Objectives:

C-3, C-13

Resource Type:

Systematic Review

Citation:

U.S. Preventive Services Task Force. Breast Cancer: Medication for Risk Reduction recommendation statement [Internet]. 2013 Sep [cited 2014 Jan 8]. Available from: http://www.uspreventiveservicestaskforce.org/uspstf13/breastcanmeds/breastcanmedsrs.htm

Tags:

Reduce Morbidity, Reduce Mortality, Reduce Risk or Incidence of Disease or Condition, Public Health, Healthcare, Clinical Practice, Informational & Educational, Primary Prevention, Patients

Syndicated Content Details:
Source URL: https://www.healthypeople.gov/2020/tools-resources/evidence-based-resource/breast-cancer-medication-for-risk-reduction-clinical
Source Agency: Office of Disease Prevention and Health Promotion, Healthy People (ODPHP-HP)
Captured Date: 2016-06-09 16:00:56.0